Combination of Second-line Antirheumatic Drugs

References

• Van der Heijde D MFM, van Leeuwen M A, van Riel P LCM, et al. Biannual radiographic assesment of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26–34
   PubMed Web of Science ®Google Scholar
• Van der Heide A, Jacobs J WG, Bijlsma J WJ, et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996; 124: 699–707
   PubMed Web of Science ®Google Scholar
• Morand E F, McCloud P I, Littlejohn G O. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992; 19: 704–8
   Google Scholar
• Situnayake R D, Grindulis K A, McConkey B. Long term treatment of rheumatoid arthritis with suphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987; 46: 177–83
   PubMed Web of Science ®Google Scholar
• Bird H A. Disease-modifying drugs for rheumatoid arthritis. Asset or liability?. Clin Rheumatol 1987; 6: 486–8
   Google Scholar
• McCarthy D J. Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians. J Rheumatol 1990; 17: 1117–8
   Google Scholar
• Fries J F. Reevaluating the therapeutic approach to rheumatoid arthritis: the 'sawtooth' strategy. J Rheumatol 1990; 17(Suppl22)12–5
   Google Scholar
• Wilke W S, Clough J D. Therapy for rheumatoid arthritis: combinations of disease modifying drugs and new paradigms of treatment. Semin Arthritis Rheum 1991; 21(Suppl 1)21–34
   PubMed Web of Science ®Google Scholar
• Wilske K R, Healey L A. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis. J Rheumatol 1990; 17(Suppl 25)4–7
   Google Scholar
• Pullar T. Combination therapy in rheumatoid arthritis. Br J Rheumatol 1991; 30: 311, letter
   Google Scholar
• Furst D E. Combination DMARD therapy: rationale and limitations. Rheumatol Eur 1995; 24(Suppl 2)190–4
   Google Scholar
• Williams H J, Ward J R, Reading J C, et al. Comparison of auranofin, methotrexate and the combination of both in the treatment of RA. Arthritis Rheum 1992; 35: 259–69
   PubMed Web of Science ®Google Scholar
• Faarvang K L, Egsmose C, Kryger P, Podenphant J, Ingeman-Nielsen M, Hansen T M. Hydroxychloroquine and sulphaslazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Ann Rheum Dis 1993; 52: 711–5
   PubMed Web of Science ®Google Scholar
• Ferraz M B, Pinheiro G RC, Helfenstein M, et al. Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A randomized placebo-controlled trial. Scand J Rheumatol 1994; 23: 231–6
   PubMed Web of Science ®Google Scholar
• Healey L A, Wilske K R. Reforming the pyramid. A plan for treating rheumatoid arthritis in the 1990s. Rheum Dis Clin North Am 1989; 15: 615–9
   PubMed Web of Science ®Google Scholar
• Schwarzer A C, Arnold M H, Kelly D, et al. The cycling of combination of antirheumatic drug therapy in rheumatoid arthritis. Br J Rheumatol 1990; 29: 445–50
   Google Scholar
• Farr M, Kitas G, Bacon P A. Sulfasalazine in rheumatoid arthritis, combination therapy with D-penicillamine or sodium aurothiomalate. Clin Rheumatol 1988; 7: 242–8
   Google Scholar
• Huskinson E C. Combination chemotherapy in rheumatoid arthritis. Br J Rheumatol 1987; 26: 243–4
   Google Scholar
• Klippel J H. Winning the battle, losing the war? Another editorial about rheumatoid arthritis. J Rheumatol 1990; 17: 1118–22
   PubMed Web of Science ®Google Scholar
• Boers M, Ramsden M. Longacting drug combinations in rheumatoid arthritis: a formal overview. J Rheumatol 1991; 18: 316–24
   PubMed Web of Science ®Google Scholar
• Paulus H E. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990; 33: 113–20
   PubMed Web of Science ®Google Scholar
• Felson D T, Anderson J J, Meenan R F. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A metanalysis. Arthritis Rheum 1994; 37: 1487–91
   PubMed Web of Science ®Google Scholar
• Willkens R F, Urowitz M B, Stablein D M, et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiological outcome assessment. Arthritis Rheum 1995; 38: 1799–806
   PubMedGoogle Scholar
• Felt J C, Osborn Th, Zoschke D, Zimmerman K, Hargrove J, Waytz R. Effect of low dose cyclosporine when added to methotrexate in rheumatoid arthritis. Arthritis Rheum 1995; 38(Suppl)S186
   Google Scholar
• Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137–41
   PubMed Web of Science ®Google Scholar
• Shaikov A V, Maximov A A, Speransky A L, Lovell D J, Gianni E H, Solovyev S K. Repetive use of pulse therapy with methylprednisolone and cyclofosfamide in addition to ral methotrexate in children with juvenile rheumatoid arthritis - preliminary results of a longterm study. J Rheumatol 1992; 19: 612–6
   PubMed Web of Science ®Google Scholar
• Truckenbrodt H, Hafner R. Combination of second-line antirheumatic drugs in the therapy of juvenile chronic arthritis. Proceedings of the 4th European Conference on Pediatric Rheumatology, HelsinkiFinland, 1996; 20–4
   Google Scholar
• Astbury C, Hill J, Bird H A. Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine. Ann Rheum Dis 1988; 47: 323–7
   Google Scholar
• Haapasaari J. Combinations of disease modifying antirheumatic drugs in juvenile rheumatoid arthritis. A retro spective analysis. Proceedings of the 4th European Conference on Pediatric Rheumatology, HelsinkiFinland, 1996; 25
   Google Scholar
• Shiroky J B, Watts C S, Neville C. Combination of methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations. Arthritis Rheum 1989; 32: 1160–4
   Google Scholar
• Nlsar M, Carlisle L, Amos R S. Methotrexate and sulpha-salazine as a combination therapy in rheumatoid arthritis. Br J Rheumatol 1994; 33: 651–4
   Google Scholar
• Haagsma C J, van Riel P LCM, van de Putte L BA. Combination of methotrexate and sulphasalazine versus methotrexate alone. A randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br J Rheumatol 1994; 33: 1049–55
   PubMedGoogle Scholar
• Haagsma C, van de Putte L, van Riel P. Sulfasalazine, methotrexate and the combination in early RA, a double blind randomised study. Arthritis Rheum 1995; 38(Suppl)S368
   Google Scholar
• O'Dell J R, Haire C E, Erikson N, et al. Treatment of rheumatoid artritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996; 334: 1287–91
   PubMed Web of Science ®Google Scholar
• Welnblatt M E, Kaplan H, Germain B F. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994; 37: 1492–8
   Google Scholar
• Winn Chatham W. Methotrexate associated rheumatoid nodulosis - improvement with addition of sulfasalazine. Arthritis Rheum 1992; 35(Suppl)S148
   Google Scholar
• Morgan S L, Bagott J E, Alarcon G A. Methotrexate and sulfasalazine combination therapy: is it worth the risk?. Arthritis Rheum 1993; 36: 281–2
   Google Scholar
• Morand E F, Axtens R SK, Littlejohn G O. Combination methotrexate and sulfasalazine therapy in patients with rheumatoid arthritis. Arthritis Rheum 1993; 36(Suppl)S53
   Google Scholar
• Shiroky J B, Neville C, Ballachey M L. Combination methotrexate and sulfasalazine in the treatment of rheumatic diseases. Arthritis Rheum 1993; 36(Suppl)S268
   Google Scholar
• Liang G C, Lessard J, Pope R M. Addition of sulfasalazine to rheumatoid arthritis patients inadequately controlled with methotrexate. Arthritis Rheum 1994; 37(Suppl)R14
   Google Scholar